• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Source Natural Foods & Herbal Supplements Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 13792.0
  • ISIN : INE679C01027
136.35 -4 (-2.50%)
  • As on 26 Jul 2025 (EOD)

  • Today’s Low

    134.30

  • Today’s High

    146.75

  • Open

    146.75

  • Perv Close

    139.85

  • 52W Low

    118.95

  • 52W High

    269.75

Key Indicators

  • P/E(TTM)

    30.23

  • Mar.Cap (₹Cr.)

    87.77

  • Div & Yield %

    0.00

  • Book Value(₹)

    34.73

  • Debt-Equity Ratio

    -2.50

  • AGM Date

    25-Jul-2025

  • EPS

    4.51

  • P/E Ratio

    30.23

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    87.77

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    6.44

  • BV (₹)

    34.70

  • Sales( ₹ in Cr.)

    44.92

  • NP (in Cr.)

    2.90

  • NP Var(%)

    65.0

  • Div%

    0.0

  • CPS (₹)

    6.10

  • EPS (₹)

    4.50

  • Traded Value (₹ in Lakhs)

    87.77

  • 52 Week High

    269.75

  • 52 Week Low

    118.95

  • Price BSE

    136.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    87.77

  • P/C Ratio

    22.30

  • P/E Ratio

    30.10

  • Price Vs.BV

    4.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 27.30 19.79 21.53 24.88 15.11 14.23
Excise Duty 0.00 0.00 0.00 0.00 1.52 1.42
Net Sales 27.30 19.79 21.53 24.88 13.59 12.81
Other Income 0.01 0.01 0.49 0.34 0.02 0.00
Stock Adjustments 1.34 0.40 0.62 -0.07 -0.33 -0.44
Total Income 28.65 20.20 22.64 25.15 13.28 12.37
EXPENDITURE :            
Raw Materials 18.12 10.25 10.05 9.84 4.53 4.37
Power and Fuel Cost 0.26 0.28 0.32 0.33 0.24 0.35
Employee Cost 2.88 3.14 3.86 2.54 2.29 2.13
Other Manufacturing Expenses 1.64 1.35 1.98 2.12 1.72 1.88
Selling and Administration Expenses 1.27 1.56 1.86 4.86 1.97 1.95
Miscellaneous Expenses 0.05 0.00 0.22 0.94 0.13 0.11
Employee Benefit Expenses 2.88 3.14 3.86 2.54 2.29 2.13
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 24.22 16.57 18.30 20.64 10.88 10.78
Operating Profit 4.43 3.62 4.34 4.50 2.41 1.59
Interest 0.21 0.27 0.24 0.10 0.23 0.20
Gross Profit 4.22 3.35 4.10 4.40 2.18 1.39
Depreciation 1.04 0.62 0.42 0.37 0.34 0.34
Profit Before Tax 3.18 2.73 3.68 4.03 1.84 1.05
Current Tax 1.12 0.61 0.91 1.32 0.43 0.24
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.32 0.01 0.34 -0.66 -0.22 -0.21
Reported Net Profit 1.74 2.12 2.43 3.37 1.64 1.03
Extraordinary Items -0.03 0.00 0.00 -0.01 0.00 0.00
Adjusted Net Profit 1.77 2.12 2.43 3.38 1.64 1.03
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 10.14 8.02 5.59 2.21 1.22 0.19
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.64 0.00
P & L Balance carried down 11.88 10.14 8.02 5.59 2.21 1.22
Dividend 0.00 0.00 0.00 0.00 0.64 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 10.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 1.00
Earnings Per Share-Unit Curr 2.70 3.30 3.78 5.24 2.55 1.59
Earnings Per Share(Adj)-Unit Curr 2.70 3.30 3.78 5.24 2.55 1.59
Book Value 30.22 27.52 24.23 20.45 15.21 13.66
Book Value(Adj)-Unit Curr 30.22 27.52 24.23 20.45 15.21 13.66

Shareholding Pattern

  • Promoter Group

    74.37%

  • Public Share Holding

    25.63%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,786,891 74.37 4,786,891 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,786,891 74.37 4,786,891 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 125,563 1.95 124,063 34
Clearing Members 0 0.00 0 0
Directors of their Relatives 8,650 0.13 8,650 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 207,283 3.22 207,133 32
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 56,431 0.88 56,431 69
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 459,065 7.13 459,065 10
Individuals holding nominal share capital up to Rs. 1 lakh 761,354 11.83 734,505 3,601
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 158 0.00 0 1
Others 27,365 0.43 27,365 1
Sub Total 1,650,040 25.63 1,621,383 3,751
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,436,931 100.00 6,408,274 3,752

Company Background

Source Natural Foods & Herbal Supplements LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Source Natural Foods & Herbal Supplements Ltd
  • BSE Code : 13792.0
  • ISIN : INE679C01027

  • Incorporation Year

    1995

  • Registered Office

    201 2nd Floor Sumeru Towers
    54/46 39 Jayanagar 4th Block, Bangaluru,
    Karnataka-560041

  • Telephone

    91-80-26087733

  • FAX

    91-80-22449505

  • Chairman

    NARAYANAN NARASIMHAN

  • Managing Director

    Arvind Varchaswi N

  • Company Secretary

    Yash Jain

  • Auditor

    Srinaga & Giridharan

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Source Natural Foods & Herbal Supplements Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Source Natural 136.35 27.30 27.30 30.23 17.73
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10